Fortress Biotech, Inc. Loss Contingency Accrual, Provision
Fortress Biotech, Inc. (FBIO) reported Loss Contingency Accrual, Provision of -$100.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-11-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyAccrualProvision · last filed 2018-11-09
- Fortress Biotech, Inc. loss contingency accrual, provision for the quarter ending 2018-06-30 was -$100.00K, a 104.35% decline year-over-year.
- Fortress Biotech, Inc. loss contingency accrual, provision for the quarter ending 2018-03-31 was $400.00K, a 60.00% decline year-over-year.
- Fortress Biotech, Inc. loss contingency accrual, provision for the quarter ending 2017-12-31 was $200.00K, a 3233.33% increase year-over-year.
- Fortress Biotech, Inc. loss contingency accrual, provision for the quarter ending 2017-06-30 was $2.30M.
| Period end | Loss Contingency Accrual, Provision 3 month | Loss Contingency Accrual, Provision 6 month | Loss Contingency Accrual, Provision 9 month |
|---|---|---|---|
| 2018-06-30 | -$100.00K 10-Q · filed 2018-11-09 | $300.00K derived: sum of 2 quarters · filed 2018-11-09 | $600.00K 10-Q · filed 2018-11-09 |
| 2018-03-31 | $400.00K 10-Q · filed 2018-08-09 | $700.00K 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $200.00K 10-Q · filed 2018-05-10 | ||
| 2017-06-30 | $2.30M 10-Q · filed 2018-11-09 | $3.30M derived: sum of 2 quarters · filed 2018-11-09 | $3.30M 10-Q · filed 2018-11-09 |
| 2017-03-31 | $1.00M 10-Q · filed 2018-08-09 | $1.00M 10-Q · filed 2018-08-09 | |
| 2016-12-31 | $6.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |